Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0Frontiers in Oncology

Postoperative prediction of disease-free survival in rectal cancer after neoadjuvant chemoradiotherapy and radical resection: a nomogram incorporating tumor regression grade and lymph node ratio

Abstract

PurposeTo develop and validate a nomogram incorporating tumor regression grade (TRG) and lymph node ratio (LNR) for predicting disease-free survival (DFS) after neoadjuvant chemoradiotherapy and radical resection for rectal cancer.MethodsThis retrospective study included 437 patients randomly divided into training (n = 305) and internal holdout validation (n = 132) cohorts, and 88 patients from an independent hospital for external validation. A nomogram estimating 3-year DFS was constructed using a multivariable Cox model. Performance was assessed using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis.ResultsMedian follow-up in the original cohort was 35.38 months. In the training and internal holdout cohorts, 106 patients (24.3%) experienced recurrence, distant metastasis, or death, as did 25 patients (28.4%) in the external validation cohort. In the multivariable model, poorer DFS was associated with TRG 2–3 (hazard ratio [HR], 2.45; 95% CI, 1.29–4.65), ypT3–4 (HR, 2.15; 95% CI, 1.12–4.15), ypN-positive disease (HR, 3.39; 95% CI, 1.73–6.63), and higher LNR (HR per 0.1 increase, 1.18; 95% CI, 1.06–1.32). The C-index was 0.830 (95% CI, 0.787–0.876) in training and 0.805 (95% CI, 0.726–0.887) in internal validation; the optimism-corrected C-index in the training cohort was 0.825. Compared with a reference model containing only ypT and ypN categories, the final model showed higher AUCs in the training cohort (0.841 vs. 0.792; AUC difference, 0.049; 95% CI, 0.025–0.088; P = 0.003), internal holdout validation cohort (0.789 vs. 0.735; AUC difference, 0.054; 95% CI, 0.005–0.108; P = 0.036), and external validation cohort (0.861 vs. 0.819; AUC difference, 0.042; 95% CI, 0.003–0.081; P = 0.034). After Holm adjustment, the P values for the AUC comparisons were 0.009, 0.068, and 0.068 in the training, internal holdout validation, and external validation cohorts, respectively. External calibration showed deviations in some probability ranges; decision curve analysis suggested potential net benefit.ConclusionsThe four-predictor postoperative nomogram showed promising discrimination for 3-year DFS, while its calibration, clinical utility, and generalizability require further evaluation in larger independent studies.

Related

  1. Prediction Models for Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
    Yun Luo, Youping Ding, Wei Liu +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  2. Identification of NUDT6 and LINGO1 as candidate genes for nCRT-associated signatures to neoadjuvant chemoradiotherapy in rectal cancer patients
    Qian Wang, Guangpeng Shen, Juntao Wang +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  3. Short-Term Outcomes and Stoma-Related Morbidity of Diverting Ileostomy After Laparoscopic Total Mesorectal Excision Following Neoadjuvant Chemoradiotherapy for Mid- and Distal Rectal Cancer: A Retrospective Single-Center Study
    Murat Derebey, Ufuk Karabacak, Ismail Alper Tarim +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial
    Yongheng Li, Rongxu Du, Jianhao Geng +25
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0Surgery & anaesthesiaCrossref
  5. Early postoperative prediction of gastrointestinal bleeding after surgery for acute type A aortic dissection: a five-variable logistic regression model benchmarked against machine learning.
    Yi Yang, Bo Jia, Yipeng Ge +7
    BMC cardiovascular disordersPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMCPMC
BibTeX
@article{du2026postoperative,
  title = {{Postoperative prediction of disease-free survival in rectal cancer after neoadjuvant chemoradiotherapy and radical resection: a nomogram incorporating tumor regression grade and lymph node ratio}},
  author = {Zhaolin Du and Yunzhi Gao and Nan Zhang and Minghao Men and Xuefeng Zheng and Yinling Li and Wenchang Yang and Yuan Gao},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = nov,
  doi = {10.3389/fonc.2026.1969622},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1969622},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Postoperative prediction of disease-free survival in rectal cancer after neoadjuvant chemoradiotherapy and radical resection: a nomogram incorporating tumor regression grade and lymph node ratio
AU  - Zhaolin Du
AU  - Yunzhi Gao
AU  - Nan Zhang
AU  - Minghao Men
AU  - Xuefeng Zheng
AU  - Yinling Li
AU  - Wenchang Yang
AU  - Yuan Gao
PY  - 2026
DA  - 2026/11/11
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1969622
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.1969622
AB  - PurposeTo develop and validate a nomogram incorporating tumor regression grade (TRG) and lymph node ratio (LNR) for predicting disease-free survival (DFS) after neoadjuvant chemoradiotherapy and radical resection for rectal cancer.MethodsThis retrospective study included 437 patients randomly divided into training (n = 305) and internal holdout validation (n = 132) cohorts, and 88 patients from an independent hospital for external validation. A nomogram estimating 3-year DFS was constructed using a multivariable Cox model. Performance was assessed using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis.ResultsMedian follow-up in the original cohort was 35.38 months. In the training and internal holdout cohorts, 106 patients (24.3%) experienced recurrence, distant metastasis, or death, as did 25 patients (28.4%) in the external validation cohort. In the multivariable model, poorer DFS was associated with TRG 2–3 (hazard ratio [HR], 2.45; 95% CI, 1.29–4.65), ypT3–4 (HR, 2.15; 95% CI, 1.12–4.15), ypN-positive disease (HR, 3.39; 95% CI, 1.73–6.63), and higher LNR (HR per 0.1 increase, 1.18; 95% CI, 1.06–1.32). The C-index was 0.830 (95% CI, 0.787–0.876) in training and 0.805 (95% CI, 0.726–0.887) in internal validation; the optimism-corrected C-index in the training cohort was 0.825. Compared with a reference model containing only ypT and ypN categories, the final model showed higher AUCs in the training cohort (0.841 vs. 0.792; AUC difference, 0.049; 95% CI, 0.025–0.088; P = 0.003), internal holdout validation cohort (0.789 vs. 0.735; AUC difference, 0.054; 95% CI, 0.005–0.108; P = 0.036), and external validation cohort (0.861 vs. 0.819; AUC difference, 0.042; 95% CI, 0.003–0.081; P = 0.034). After Holm adjustment, the P values for the AUC comparisons were 0.009, 0.068, and 0.068 in the training, internal holdout validation, and external validation cohorts, respectively. External calibration showed deviations in some probability ranges; decision curve analysis suggested potential net benefit.ConclusionsThe four-predictor postoperative nomogram showed promising discrimination for 3-year DFS, while its calibration, clinical utility, and generalizability require further evaluation in larger independent studies.
SN  - 2234-943X
ER  -